[HTML][HTML] Prevalence of periodontal disease, its association with systemic diseases and prevention
MA Nazir - International journal of health sciences, 2017 - ncbi.nlm.nih.gov
Periodontal diseases are prevalent both in developed and developing countries and affect
about 20-50% of global population. High prevalence of periodontal disease in adolescents …
about 20-50% of global population. High prevalence of periodontal disease in adolescents …
An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes
Aim To provide an update of the review by Taylor (Journal of Clinical Periodontology, 2013,
40, S113) regarding the scientific evidence of the biological association between …
40, S113) regarding the scientific evidence of the biological association between …
Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial
Background Chronic inflammation is believed to be a major mechanism underlying the
pathophysiology of type 2 diabetes. Periodontitis is a cause of systemic inflammation. We …
pathophysiology of type 2 diabetes. Periodontitis is a cause of systemic inflammation. We …
Periodontal systemic associations: review of the evidence
Aim: To critically appraise recent research into associations between periodontal disease
and systemic diseases and conditions specifically respiratory disease, chronic kidney …
and systemic diseases and conditions specifically respiratory disease, chronic kidney …
A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes
Aims To review the evidence for the molecular and cellular processes that may potentially
link periodontal disease and diabetes. The pathogenic roles of cytokines and metabolic …
link periodontal disease and diabetes. The pathogenic roles of cytokines and metabolic …
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus
TC Simpson, JC Weldon… - Cochrane Database …, 2015 - cochranelibrary.com
Background Glycaemic control is a key issue in the care of people with diabetes mellitus
(DM). Periodontal disease is the inflammation and destruction of the underlying supporting …
(DM). Periodontal disease is the inflammation and destruction of the underlying supporting …
Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta‐analysis
WJ Teeuw, DE Slot, H Susanto… - Journal of clinical …, 2014 - Wiley Online Library
Aim Systematic review and meta‐analyses to study the robustness of observations that
treatment of periodontitis improves the atherosclerotic profile. Material and Methods …
treatment of periodontitis improves the atherosclerotic profile. Material and Methods …
Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta‐analysis
S Engebretson, T Kocher - Journal of clinical periodontology, 2013 - Wiley Online Library
Context The effect of periodontal therapy on diabetes outcomes has not been established.
Objective This update examines the effect of periodontal treatment on diabetes outcomes …
Objective This update examines the effect of periodontal treatment on diabetes outcomes …
The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial
SP Engebretson, LG Hyman, BS Michalowicz… - Jama, 2013 - jamanetwork.com
Importance Chronic periodontitis, a destructive inflammatory disorder of the supporting
structures of the teeth, is prevalent in patients with diabetes. Limited evidence suggests that …
structures of the teeth, is prevalent in patients with diabetes. Limited evidence suggests that …
Evidence that periodontal treatment improves biomarkers and CVD outcomes
F D'Aiuto, M Orlandi, JC Gunsolley - Journal of periodontology, 2013 - Wiley Online Library
Aim: The aim of this review was to critically appraise the evidence on the impact of
periodontal treatment of cardiovascular diseases (CVDs) biomarkers and outcomes …
periodontal treatment of cardiovascular diseases (CVDs) biomarkers and outcomes …